A study reported that a new CLLflow score including combination of CD5/CD23, FMC7, CD79b, and CD200 showed sensitivity and specificity of 97.1% and 87.2%, respectively in the diagnosis of CLL.15 This evidence concerns the gene MS4A1 and B-cell chronic lymphocytic leukemia.